Clinical diagnostic
Clinical testing in patient care for Kx antigen follows published minimum quality and operational requirements,[8] similar to red cell genotyping for any of the other recognized blood group systems. Molecular analysis can identify gene variants (alleles) that may affect Kx antigen expression on the red cell membrane.
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000047597 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000015342 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Arnaud L, Salachas F, Lucien N, Maisonobe T, Le Pennec PY, Babinet J, et al. (March 2009). "Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome". Transfusion. 49 (3): 479–484. doi:10.1111/j.1537-2995.2008.02003.x. PMID 19040496. S2CID 27198922.
- ↑ Malandrini A, Fabrizi GM, Truschi F, Di Pietro G, Moschini F, Bartalucci P, et al. (June 1994). "Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: report of a family". Journal of the Neurological Sciences. 124 (1): 89–94. doi:10.1016/0022-510X(94)90016-7. PMID 7931427. S2CID 27859436.
- ↑ Ho MF, Monaco AP, Blonden LA, van Ommen GJ, Affara NA, Ferguson-Smith MA, et al. (February 1992). "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21". American Journal of Human Genetics. 50 (2): 317–330. PMC 1682457. PMID 1734714.
- ↑ Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens (7 ed.). Association for the Advancement of Blood & Biotherapies. January 1, 2025. ISBN 978-1-56395-516-7.
- ↑ Jung HH, Russo D, Redman C, Brandner S (October 2001). "Kell and XK immunohistochemistry in McLeod myopathy". Muscle & Nerve. 24 (10): 1346–1351. doi:10.1002/mus.1154. PMID 11562915. S2CID 44749645.